The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha
Open accessAbstract
Isothiocyanates and phenolic antioxidants can prevent cancer through activation of Nrf2 (NF-E2 p45-related factor 2), a transcription factor that controls expression of cytoprotective genes through the antioxidant response element (ARE) enhancer. Using a human mammary MCF7-derived AREc32 reporter cell line, we now report that all-trans retinoic acid (ATRA), and other retinoic acid receptor alpha (RARα) agonists, markedly reduces the ability of Nrf2 to mediate induction of ARE-driven genes by cancer chemopreventive agents including the metabolite of butylated hydroxyanisole, tert -butylhydroquinone (tBHQ). The basal and tBHQ-inducible expression of aldo-keto reductase ( AKR ) AKR1C1 and AKR1C2 genes, which are regulated by Nrf2, was also repressed by ATRA in AREc32 cells. Antagonists of RARα augmented induction of ARE-driven gene expression by tBHQ, as did knockdown of RARα by using RNAi. The expression of the ARE-gene battery was increased in the small intestine of mice fed on a vitamin A-deficient diet, and this increase was repressed by administration of ATRA. By contrast, in the small intestine of Nrf2 null mice, the expression of ARE-driven genes was not affected by vitamin A status. In MCF7 cells, ATRA did not block the nuclear accumulation of Nrf2 but reduced the binding of Nrf2 to the ARE enhancer as a consequence of forming a complex with RARα. These data suggest that cross-talk between Nrf2 and RARα could markedly influence the sensitivity of cells to electrophiles and oxidative stressors and, as a consequence, to carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schreiber, E., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
AP-1 as a regulator of cell life and death
Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961
McMahon, M., Itoh, K., Yamamoto, M., & Hayes, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300931200 · Cited by 1,141
Ramos-Gomez, M., Kwak, M.-K., Dolan, P. M., Itoh, K., Yamamoto, M., Talalay, P., & Kensler, T. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051618798 · Cited by 1,102
Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
Singh, A., Misra, V., Thimmulappa, R. K., Lee, H., Ames, S., Hoque, M. O., Herman, J. G., Baylin, S. B., Sidransky, D., Gabrielson, E., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030420 · Cited by 1,060
Glutathione-Associated Enzymes In Anticancer Drug Resistance
Tew, K. D. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3143 · Cited by 856
McMahon, M. J., Itoh, K., Yamamoto, M. P., Chanas, S. A., Henderson, C. J., McLellan, L. I., Wolf, C. R., Cavin, C., & Hayes, J. D. (2001) · PubMed · Cited by 732
Self-citationKwak, M.-K., Wakabayashi, N., Itoh, K., Motohashi, H., Yamamoto, M., & Kensler, T. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211898200 · Cited by 660
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer
Liby, K. T., Yore, M. M., & Sporn, M. B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2129 · Cited by 637
Phytochemicals from Cruciferous Plants Protect against Cancer by Modulating Carcinogen Metabolism
Talalay, P., & Fahey, J. W. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.11.3027s · Cited by 609
Retinoic acid is a negative regulator of AP-1-responsive genes.
Schüle, R., Rangarajan, P., Yang, N., Kliewer, S., Ransone, L. J., Bolado, J., Verma, I. M., & Evans, R. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6092 · Cited by 526
NIOI, P., McMAHON, M., ITOH, K., YAMAMOTO, M., & HAYES, J. D. (2003) · Biochemical Journal · doi:10.1042/bj20030754 · Cited by 507
Self-citationMcMahon, M., Thomas, N., Itoh, K., Yamamoto, M., & Hayes, J. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601119200 · Cited by 485
Self-citationDhakshinamoorthy, S., Jain, A. K., Bloom, D. A., & Jaiswal, A. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500166200 · Cited by 414
Aldo-Keto Reductases and Bioactivation/Detoxication
Jin, Y., & Penning, T. M. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105337 · Cited by 383
Transcriptional Regulation of the Antioxidant Response Element
Nguyen, T., Huang, H. C., & Pickett, C. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000361200 · Cited by 378
Iida, K., Itoh, K., Kumagai, Y., Oyasu, R., Hattori, K., Kawai, K., Shimazui, T., Akaza, H., & Yamamoto, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1906 · Cited by 370
p53 Suppresses the Nrf2-dependent Transcription of Antioxidant Response Genes
Faraonio, R., Vergara, P., Di Marzo, D., Pierantoni, M. G., Napolitano, M., Russo, T., & Cimino, F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605707200 · Cited by 349
Hayes, J. D., Chanas, S. A., Henderson, C. J., McMahon, M., Sun, C., Moffat, G. J., Wolf, C. R., & Yamamoto, M. (2000) · Biochemical Society Transactions · doi:10.1042/bst0280033 · Cited by 320
Self-citationWang, X. J., Hayes, J. D., & Wolf, C. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2298 · Cited by 315
Self-citationWang, J.-S., Shen, X., He, X., Zhu, Y.-R., Zhang, B.-C., Wang, J.-B., Qian, G.-S., Kuang, S.-Y., Zarba, A., Egner, P. A., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.4.347 · Cited by 307
Retinoic Acid Blocks Adipogenesis by Inhibiting C/EBPβ-Mediated Transcription
Schwarz, E. J., Reginato, M. J., Shao, D., Krakow, S. L., & Lazar, M. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1552 · Cited by 302
Fukumoto, S.-I., Yamauchi, N., Moriguchi, H., Hippo, Y., Watanabe, A., Shibahara, J., Taniguchi, H., Ishikawa, S., Ito, H., Yamamoto, S., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1238 · Cited by 289
Molecular mechanisms of drug resistance
Hayes, J. D., & Wolf, C. R. (1990) · Biochemical Journal · doi:10.1042/bj2720281 · Cited by 279
Self-citationRetinoic acid receptors and cancers
Soprano, D. R., Qin, P., & Soprano, K. J. (2004) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132407 · Cited by 270
Activation of mammalian retinoid X receptors by the insect growth regulator methoprene.
Harmon, M. A., Boehm, M. F., Heyman, R. A., & Mangelsdorf, D. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.13.6157 · Cited by 240
O'CONNOR, T., IRELAND, L. S., HARRISON, D. J., & HAYES, J. D. (1999) · Biochemical Journal · doi:10.1042/bj3430487 · Cited by 217
Self-citationStrategy and planning for chemopreventive drug development: Clinical development plans II
Kelloff, G. J., Crowell, J. A., Hawk, E. T., Steele, V. E., Lubet, R. A., Boone, C. W., Covey, J. M., Doody, L. A., Omenn, G. S., Greenwald, P., et al. (1996) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240630705 · Cited by 196
Kelly, V. P., Ellis, E. M., Manson, M. M., Chanas, S. A., Moffat, G. J., McLeod, R., Judah, D. J., Neal, G. E., & Hayes, J. D. (2000) · PubMed · Cited by 164
Self-citationVitamin A, differentiation and cancer
Love, J. M., & Gudas, L. J. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90051-5 · Cited by 148
Glutathione and glutathione-dependent enzymes in cancer drug resistance
McLellan, L. I., & Wolf, C. R. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0083 · Cited by 146
Self-citationUtility of siRNA against Keap1 as a strategy to stimulate a cancer chemopreventive phenotype
Devling, T. W. P., LINDSAY, C. D., McLellan, L. I., McMahon, M. J., & Hayes, J. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501475102 · Cited by 136
Self-citationCammas, F. M., Oulad‐Abdelghani, M., Vonesch, J., Huss-Garcia, Y., Chambon, P., & Losson, R. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.17.3439 · Cited by 113
Rochette‐Egly, C., & Chambon, P. (2001) · PubMed · doi:10.14670/hh-16.909 · Cited by 86
Wang, X. J., CHAMBERLAIN, M., Vassieva, O., Henderson, C. J., & Wolf, C. R. (2005) · Biochemical Journal · doi:10.1042/bj20042087 · Cited by 65
Self-citationApoptosis during Retinoic Acid-Induced Differentiation of F9 Embryonal Carcinoma Cells
Atencia, R., García‐Sánz, R., Unda, F. J., & Aréchaga, J. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1304 · Cited by 63
Synthetic Retinoids and Their Nuclear Receptors
Dawson, M. I. (2004) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011043352975 · Cited by 47
Strategy and planning for chemopreventive drug development: Clinical development plans
Kelloff, G. J., Crowell, J. A., Boone, C. W., Steele, V. E., Lubet, R. A., Greenwald, P., Alberts, D. S., Covey, J. M., Doody, L. A., Knapp, G. G., et al. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240560906 · Cited by 43
Retinoic Acid Receptor-Nuclear Factor-Interleukin 6 Antagonism
DiSepio, D., Malhotra, M., Chandraratna, R. A. S., & Nagpal, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25555 · Cited by 42
Pfitzner, E., Becker, P. B., Rolke, A., & Schüle, R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12265 · Cited by 34
Moffat, G. J., McLaren, A. W., & Wolf, C. R. (1997) · Biochemical Journal · doi:10.1042/bj3240091 · Cited by 25
Self-citationHuman Lung Cancer Chemoprevention Strategies
Omenn, G. S. (2004) · CHEST Journal · doi:10.1378/chest.125.5_suppl.123s · Cited by 13
Cited by
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Cuadrado, A., Rojo, A. I., Wells, G., Hayes, J. D., Cousin, S. P., Rumsey, W. L., Attucks, O. C., Franklin, S., Levonen, A.-L., Kensler, T. W., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0008-x · Cited by 1,438
Self-citationThe emerging role of the Nrf2–Keap1 signaling pathway in cancer
Jaramillo, M. C., & Zhang, D. D. (2013) · Genes & Development · doi:10.1101/gad.225680.113 · Cited by 1,297
Glutathione metabolism in cancer progression and treatment resistance
Bansal, A., & Simon, M. C. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201804161 · Cited by 1,233
The cytoprotective role of the Keap1–Nrf2 pathway
Baird, L., & Dinkova-Kostova, A. T. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0674-5 · Cited by 1,027
NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
Hayes, J. D., & McMahon, M. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.12.008 · Cited by 869
Self-citation
Metadata
- Authors
- Wang, X. J., Hayes, J. D., Henderson, C. J., & Wolf, C. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-12-04
- Volume
- 104
- Issue
- 49
- Pages
- 19589-19594
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2060241324
- Cited by
- 309
- References
- 43
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.